Zinlirvimab
Zinlirvimab is a human IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop) [1][2].
Product Specifications
CAS Number
[2417213-75-1]
Product Name Alternative
10-1074
UNSPSC
12352203
Target
HIV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/zinlirvimab.html
Purity
98.87
Solubility
10 mM in DMSO|H2O
Smiles
[Zinlirvimab]
Molecular Weight
(143.58 kDa)
References & Citations
[1]Kuritzkes DR. Broadly neutralizing antibodies and long-acting antiretroviral drugs as treatments for HIV. Curr Opin HIV AIDS. 2023 Jul 1;18 (4) :225-228.|[2]Zinlirvimab. IMGT/mAb-DB.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7210907-01 48 Well
Goat Complement C1q tumor necrosis factor-related protein 9A (C1QTNF9) ELISA Kit
Ask
View Details 
MBS7210907-02 96 Well
Goat Complement C1q tumor necrosis factor-related protein 9A (C1QTNF9) ELISA Kit
Ask
View Details MBS7210907-03 5x 96 Well
Goat Complement C1q tumor necrosis factor-related protein 9A (C1QTNF9) ELISA Kit
Ask
View Details MBS7210907-04 10x 96 Well
Goat Complement C1q tumor necrosis factor-related protein 9A (C1QTNF9) ELISA Kit
Ask
View Details MBS6154669-01 0.1 mL
RING Finger Protein 125 (RNF125, E3 Ubiquitin-protein Ligase RNF125, T-cell RING Activation Protein 1, TRAC1, TRAC-1) (HRP)
Ask
View Details